Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Pediatric Dermatology|December 29, 2025
Delayed Bullous Drug Eruption Induced by Elexacaftor/Tezacaftor/IvacaftorTatiana Ninkov, Megan Yap, Nima Mesbah Ardakani, et al.Dermatology and Therapy|September 15, 2017
High Patient Satisfaction with Daylight-Activated Methyl Aminolevulinate Cream in the Treatment of Multiple Actinic Keratoses: Results of an Observational Study in AustraliaJo-Ann See, Kurt Gebauer, Jason K Wu, et al.The Australasian Journal of Dermatology|February 28, 2025
From Monotherapy to Adjunctive Therapies: Application of Dermocosmetics in Acne Management Across Australia and New ZealandRyan De Cruz, Rebecca Nguyen, Peggy Chen, et al.The Australasian Journal of Dermatology|July 13, 2016
The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian settingMarius Rademaker, Monisha Gupta, Megan Andrews, et al.The Australasian Journal of Dermatology|August 11, 2020
Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrativeMarius Rademaker, Katherine Armour, Christopher Baker, et al.Journal of the American Academy of Dermatology|March 30, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b studyKurt Gebauer, Lynda Spelman, Paul S Yamauchi, et al.The Australasian Journal of Dermatology|May 26, 2017
Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis CollaborationMarius Rademaker, Karen Agnew, Megan Andrews, et al.The Australasian Journal of Dermatology|September 19, 2019
Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrativeMarius Rademaker, Karen Agnew, Megan Andrews, et al.Journal of the American Academy of Dermatology|December 26, 2024
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trialHoward L Sofen, Kurt Gebauer, Lynda Spelman, et al.The Australasian Journal of Dermatology|November 23, 2024
Australasian hidradenitis suppurativa management guidelinesJohn Frew, Annika Smith, Pablo Fernandez Penas, et al.Pageof 4